2020
Red blood cell alloimmunization and sickle cell disease: a narrative review on antibody induction
Hendrickson JE. Red blood cell alloimmunization and sickle cell disease: a narrative review on antibody induction. Annals Of Blood 2020, 5: 33-33. PMID: 33554044, PMCID: PMC7861514, DOI: 10.21037/aob-2020-scd-01.Peer-Reviewed Original ResearchSickle cell diseaseRBC alloantibody formationRace-matched controlsAlloantibody formationCell diseaseImmune systemRed blood cell alloimmunizationRed blood cell alloantibodiesWhite blood cell subsetsAntigen variantsFcγ receptor polymorphismsT cell subsetsBlood cell subsetsType 1 interferonFree hemeRBC alloimmunizationRBC alloantibodiesAntibody inductionPlatelet countCell subsetsReceptor polymorphismsHigh prevalenceMurine studiesMurine modelHuman studies
2019
Chapter 49 Neonatal and Pediatric Transfusion Medicine
Zerra P, Hendrickson J, Josephson C. Chapter 49 Neonatal and Pediatric Transfusion Medicine. 2019, 295-299. DOI: 10.1016/b978-0-12-813726-0.00049-0.Peer-Reviewed Original Research
2017
Red blood cell alloimmunisation: induction of immunity and potential mitigation strategies
Hendrickson J. Red blood cell alloimmunisation: induction of immunity and potential mitigation strategies. ISBT Science Series 2017, 13: 105-111. DOI: 10.1111/voxs.12360.Peer-Reviewed Original ResearchAnimal modelsChronic inflammatory disease statesRBC unitsAntigen-specific toleranceT-cell markersInduction of immunityInflammatory disease statesHumoral immune responseHumoral immune responsivenessAlloantibody developmentRBC alloimmunisationDonor antigensDendritic cellsRBC alloantibodiesRBC transfusionTransfusion recipientsImmune responsivenessRBC exposureRisk factorsMurine studiesForeign antigensImmune responseCD 4Danger signalsImmune system
2014
The RBC as a Target of Damage
Hendrickson J, Tormey C. The RBC as a Target of Damage. 2014, 3068-3080. DOI: 10.1016/b978-0-12-386456-7.06203-1.Chapters
2013
Alterations In Specific Immune Cell Subsets In Children With Sickle Cell Disease
Nickel R, Hendrickson J, Horan J, Garrett A, Robertson J, Osunkwo I, Kean L. Alterations In Specific Immune Cell Subsets In Children With Sickle Cell Disease. Blood 2013, 122: 2208. DOI: 10.1182/blood.v122.21.2208.2208.Peer-Reviewed Original ResearchSickle cell diseaseWhite blood cellsTotal white blood cellsChronic transfusionImmune cell subsetsHU patientsImmune cell populationsSCD patientsT cellsCell subsetsHealthy controlsCell diseaseB cellsGraft rejectionNK cellsImmune systemBone marrow transplant rejectionT-cell subset analysisCell populationsRed blood cell alloimmunizationPediatric sickle cell diseaseSpecific immune cell subsetsDifferent immune cell populationsAbnormal immune activationB cell analysisChapter 47 Neonatal and Pediatric Transfusion Medicine
Hendrickson J, Josephson C. Chapter 47 Neonatal and Pediatric Transfusion Medicine. 2013, 301-305. DOI: 10.1016/b978-0-12-397164-7.00047-1.Peer-Reviewed Original Research
2012
Effects of genetic, epigenetic, and environmental factors on alloimmunization to transfused antigens: Current paradigms and future considerations
Zimring J, Stowell S, Johnsen J, Hendrickson J. Effects of genetic, epigenetic, and environmental factors on alloimmunization to transfused antigens: Current paradigms and future considerations. Transfusion Clinique Et Biologique 2012, 19: 125-131. PMID: 22682308, DOI: 10.1016/j.tracli.2012.03.002.Peer-Reviewed Original ResearchConceptsImmune systemLarge observational studiesMinority of recipientsHuman immune systemTransfused cellsContext of transfusionRed blood cellsTransfusion therapyObservational studyImmune responseAdditional antibodiesCoagulation factorsAlloimmunizationClinical barriersBlood cellsRecent mechanistic studiesRecipientsTransfusionPatientsPotential causesAntigenAntibodiesMicrobial pathogensCellsResponse
2009
Chapter 42 Neonatal and Pediatric Transfusion Medicine
Hendrickson J, Josephson C. Chapter 42 Neonatal and Pediatric Transfusion Medicine. 2009, 235-239. DOI: 10.1016/b978-0-12-374432-6.00042-7.Peer-Reviewed Original ResearchCardiopulmonary diseaseSevere cardiopulmonary diseaseSmall-volume transfusionsFebrile transfusion reactionsPediatric transfusion medicineHLA alloimmunizationSymptomatic anemiaMajor surgeryPediatric patientsPremature infantsCMV transmissionTransfusion therapyNeonatal patientsPhysiologic changesTransfusion reactionsImmune systemNeonatesFetal periodAnticoagulant-preservative solutionInfantsTransfusionRBC productsTransfusion medicineDlPatients